VITAMIN D RECEPTORS GENES POLYMORPHISMS AND OXIDATIVE DNA DAMAGE AMONG KURD PATIENTS WITHTYPE 2 DIABETES, KURDISTAN REGION (IRAQ)
Background: Although the relationship between vitamin D deficiency and oxidative DNA damage has been previously reported, few studies have examined vitamin D receptor (VDR) gene polymorphisms for association with the risk of DNA damage. This study aimed to identify vitamin D receptor genotypes in patients with type 2 diabetes and healthy subjects, as well as identify the relationship with oxidative DNA damage.
Methods: The study enrolled 162 subjects, 96 with type 2 diabetes and 66 healthy individuals were randomly selected to participate in prospective genotype detection by standard polymerase chain reaction methods and restriction fragment length polymorphism (PCR-RFLP). The polymorphism of FokI and BsmI genes and its association with DNA damage were determined. The main outcome measures were oxidative DNA damage marker including serum 8-hydroxy 2-deoxy guanosine (8-OHdG) and 25 hydroxy vitamin D [25(OH) D].
Results: Notable statistical significance exists in the frequency of genotype and allele of FokI (VDR 2228570 C>T) in patient group (OR 9.7, P=0.01) compared with the healthy individual group. No significant difference was found in the patient group (OR 0.74, p=0.66) in the frequency of genotype and allele of BsmI (VDR 1544410 A>G.). The frequency allele carrier of the (VDR 2228570) C allele was higher in the patients sub- group with high DNA damage than in the healthy individuals (OR=1.22, CI=0.02-18.9, p= 0.70). The frequency allele carrier of the (VDR 1544410) G allele was also higher in the patients sub-group with a high level of DNA damage than in the healthy individuals (OR=1.38, CI=0.13-16.8, p=0.57).
Conclusion: Our results suggest a significant relationship between DNA damage and the gene polymorphism FokI (VDR 228570 C>T) CC and its allele C among diabetic patients. Additionally, our results suggest that the high prevalence of FokI (VDR 228570 C>T) polymorphism among patients group may be a genetic marker of susceptibility for diabetes in our population
sor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ. 2014; 348:g1903.
2. Al-Timimi DJ, Hazim SH Ahmed IH. Vitamin D status and metabolic abnormality profile among siblings of patients with type 2 diabetes mellitus. Duhok Med J. 2015; 9(2):1-9.
3. Garland CF, Gorham ED, Mohr SB, Garland FC. Vitamin D for cancer prevention: global perspective. Annals of epidemiology.2009; 19(7):468-83.
4. Nair-Shalliker V, Armstrong BK, Fenech M. Does vitamin D protect against DNA damage? Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2012; 733(12): 50-7.
5. Wang EW, Collins AR, Pang MY, Siu PP, Lai CK, Woo J, et al. Vitamin D and oxidation-induced DNA damage: is there a connection? Mutagenesis. 2016; 31(6):655-9.
6. Nishikawa M. Reactive oxygen species in tumor metastasis. Cancer letters .2008; 266(1):53-9.
7. Zgaga L, Theodoratou E, Farrington SM, Din FV, Ooi LY, Glodzik D, et al. Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer. Journal of Clinical Oncology. 2014; 32(23): 2430-9.
8. Alvarez JA, Ashraf AP, Hunter GR, Gower BA. Serum 25-hydroxyvitamin D and parathyroid hormone are independent determinants of whole-body insulin sensitivity in women and may contribute to lower insulin sensitivity in African Americans. The American journal of clinical nutrition. 2010; 92(6): 1344-9.
9. Graziano S, Johnston R, Deng O, Zhang J, Gonzalo S. Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence. Oncogene. 2016; 35(41): 5362.
10. Iranpur M, Esmailizadeh A, Horriat R, Asadi K, Shiran B, Sorkheh K, et al. Rapid extraction of high quality DNA from
11. Brożyna AA, Jozwicki W, Janjetovic Z, Slominski AT. Expression of vitamin D receptor decreases during progression of pigmented skin lesions. Human pathology. 2011; 42(5): 618-31.
12. Filus A, Trzmiel A, KuliczkowskaPłaksej J, Tworowska U, Jędrzejuk D, Milewicz A, et al. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. The Aging Male. 2008; 11(3): 134-9.
13. Sung C-C, Liao M-T, Lu K-C, Wu CC. Role of vitamin D in insulin resistance. BioMed Research International .2012; 2012.
14. Ye W-Z, Reis AF, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G. Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. European Journal of Endocrinology .2001; 145(2):181-6.
15. Oh J-Y, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in communitydwelling older adults: the Rancho Bernardo Study. Metabolism-Clinical and Experimental. 2002; 51(3): 356-9.
16. Narvaez CJ, Matthews D, Broun E, Chan M, Welsh J. Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology. 2009; 150(2): 651-61.
17. Fedirko V, Bostick RM, Long Q, Flanders WD, McCullough ML,
18. Elhusseini H, Elkafas H, Abdelaziz M, Halder S, Atabiekov I, Eziba N, et al. Diet-induced vitamin D deficiency triggers inflammation and DNA damage profile in murine myometrium. International journal of women's health .2018; 10:503.
19. Tawfeek M. Vitamin D receptor BsmI gene polymorphisms and gestational diabetes mellitus: a Saudi study. 2011.
20. Mackawy AM, Badawi ME. Association of vitamin D and vitamin D receptor gene polymorphisms with chronic inflammation, insulin resistance and metabolic syndrome components in type 2 diabetic Egyptian patients. Meta gene 2014; 2: 540-56.
21. Ban Y, Taniyama M, Yanagawa T, Yamada S, Maruyama T, Kasuga A, et al. Vitamin D receptor initiation codon polymorphism influences genetic susceptibility to type 1 diabetes mellitus in the Japanese population. BMC Medical Genetics .2001; 2(1): 7.